Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder AsiaPacific Fund Regulatory News (SDP)

Share Price Information for Schroder AsiaPacific Fund (SDP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 521.00
Bid: 520.00
Ask: 525.00
Change: 0.00 (0.00%)
Spread: 5.00 (0.962%)
Open: 521.00
High: 522.00
Low: 520.00
Prev. Close: 521.00
SDP Live PriceLast checked at -
Schroder AsiaPacific is an Investment Trust

To achieve capital growth by investing in equities of companies in Asia, (excluding the Middle East and Japan) and the Far Eastern countries bordering the Pacific Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results analysis from Kepler Trust Intelligence

13 Dec 2023 07:00

RNS Number : 5535W
Schroder AsiaPacific Fund PLC
13 December 2023
 

Schroder AsiaPacific (SDP)

13/12/2023

Results analysis from Kepler Trust Intelligence

Schroder AsiaPacific (SDP) has released its financial results for the year ending 30/09/2023. Over the year, the trust saw its NAV increase by 2.9% on a total return basis, versus 1.5% for the trust's benchmark. The AIC Asia Pacific sector delivered an average return of -1.4% over the same period.

Outperformance has been driven by good stock selection, and in part by an underweight allocation to China. The index delivered positive returns in local currency terms, but was impacted by translation effects . Regardless, SDP has now delivered outperformance at an annualised rate of 2.4% over the past ten years.

The board were active in buying back shares totalling 6m shares in the year, with a further 1.3m in the period post results, a total amount equal to 4.7% of the current share count.

The trust declared a dividend of 12p per share, in line with the amount paid in the previous year. This was fully covered by income and equated to a yield of 2.5% at the date of publication.

Gearing was 2.1% at the end of the period, supported by a renewal of a £75m revolving credit facility in June 2023.

Chairman James Williams commented on the difficult market backdrop saying: "It is clear that market conditions in Asia - and indeed globally - will continue to be volatile ? [but it is] "an ideal time for our managers' investment strategy which remains focused on companies with structural and sustainable competitive advantages trading at attractive valuations."

Kepler View

Whilst the Asian region has been through a period of volatility over the period covered by the report, managers Richard Sennitt and Abbas Barkhordar have delivered another impressive year of performance, with a total return 2.5% ahead of the benchmark and significantly ahead of the peer group.

The period has seen a series of market gyrations, which has led to a divergence in returns. In our opinion, this environment is likely to be beneficial for stock pickers and is a major reason behind the strong relative performance. Currency translations have had an impact on performance. In local currency terms, all but two of the eight major economies in the region had positive returns. However, when translated back to sterling, these returns were notably reduced.

The managers were underweight China which contributed to performance though this was balanced with an overweight to Hong Kong. This was a headwind albeit offset by good stock selection. The managers have been adding to both countries selectively. Taiwan contributed to performance, particularly in the technology holdings. Stock selection was also positive. The managers like India, but remain selective. We believe this pragmatic approach is one of the key drivers behind the consistent outperformance of the trust.

The trust's shares have remained at a steady discount to NAV across the year. The board has recognised this and has been active in trying to stabilise the discount through buy backs which, in our opinion, is a positive sign to investors.

The trust also reduced the upper tier of the management fees to 0.6% from 0.7%.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAMZMMZRZKGFZM
Date   Source Headline
9th May 20246:13 pmRNSTransaction in Own Shares
9th May 202410:42 amRNSNet Asset Value(s)
8th May 20245:08 pmRNSTransaction in Own Shares
8th May 202410:47 amRNSNet Asset Value(s)
7th May 20245:42 pmRNSTransaction in Own Shares
7th May 202410:37 amRNSNet Asset Value(s)
3rd May 20244:42 pmRNSTransaction in Own Shares
3rd May 202410:56 amRNSNet Asset Value(s)
2nd May 202410:44 amRNSNet Asset Value(s)
1st May 20244:49 pmRNSTransaction in Own Shares
1st May 20243:25 pmRNSPortfolio Update
1st May 202410:40 amRNSNet Asset Value(s)
30th Apr 20245:28 pmRNSTotal Voting Rights
30th Apr 202410:20 amRNSNet Asset Value(s)
29th Apr 20244:38 pmRNSTransaction in Own Shares
29th Apr 202410:23 amRNSNet Asset Value(s)
26th Apr 20245:04 pmRNSTransaction in Own Shares
26th Apr 202410:45 amRNSNet Asset Value(s)
25th Apr 20244:28 pmRNSTransaction in Own Shares
25th Apr 202410:42 amRNSNet Asset Value(s)
24th Apr 20245:31 pmRNSTransaction in Own Shares
24th Apr 202410:27 amRNSNet Asset Value(s)
23rd Apr 20245:14 pmRNSTransaction in Own Shares
23rd Apr 202411:08 amRNSNet Asset Value(s)
22nd Apr 20244:53 pmRNSTransaction in Own Shares
22nd Apr 20244:28 pmRNSCompliance with Market Abuse Regulations
22nd Apr 202410:33 amRNSNet Asset Value(s)
19th Apr 20244:52 pmRNSTransaction in Own Shares
19th Apr 202410:14 amRNSNet Asset Value(s)
18th Apr 202410:17 amRNSNet Asset Value(s)
17th Apr 20244:37 pmRNSTransaction in Own Shares
17th Apr 202410:36 amRNSNet Asset Value(s)
16th Apr 20244:43 pmRNSTransaction in Own Shares
16th Apr 202410:35 amRNSNet Asset Value(s)
15th Apr 20244:46 pmRNSPortfolio Update
15th Apr 202411:38 amRNSNet Asset Value(s)
12th Apr 20244:30 pmRNSTransaction in Own Shares
12th Apr 202410:59 amRNSNet Asset Value(s)
11th Apr 20244:52 pmRNSTransaction in Own Shares
11th Apr 202410:27 amRNSNet Asset Value(s)
10th Apr 202410:24 amRNSNet Asset Value(s)
9th Apr 20245:04 pmRNSTransaction in Own Shares
9th Apr 202411:05 amRNSNet Asset Value(s)
8th Apr 20244:42 pmRNSTransaction in Own Shares
8th Apr 202411:19 amRNSNet Asset Value(s)
5th Apr 202410:25 amRNSNet Asset Value(s)
4th Apr 202411:00 amRNSNet Asset Value(s)
3rd Apr 20244:46 pmRNSHolding(s) in Company
3rd Apr 20244:45 pmRNSTransaction in Own Shares
3rd Apr 202410:34 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.